#United States #Ann Arbor #Forever Labs #SuperShot #Kevin Virgil

Forever Labs Spins Out SuperShot Inc. and Appoints Kevin Virgil as New CEO

Forever Labs, a leader in stem cell banking and regenerative medicine, has made a significant announcement that marks an important shift in its operational structure. The company has formally spun out SuperShot Inc., which will now function as an independent entity. This strategic decision is aimed at enabling both Forever Labs and SuperShot to concentrate on their unique missions while maintaining strong collaborative ties.

In conjunction with this transition, Forever Labs has appointed Kevin Virgil as the new Chief Executive Officer. Virgil is expected to bring fresh energy and a wealth of entrepreneurial experience to the organization, particularly as the company seeks to innovate within the realms of stem cell preservation and therapeutic solutions. Steven Clausnitzer and Mark Katakowski, the co-founders of Forever Labs, will take the reins at SuperShot Inc., ensuring that it is guided by leaders who understand its core mission and immense potential.

This significant restructuring is seen as a natural evolution for both companies. Clausnitzer stated, “SuperShot has reached a stage that warrants dedicated leadership and resources. We are excited to focus our efforts on SuperShot while having the confidence that Forever Labs remains in capable hands with Kevin at the forefront.” The forward-looking vision shared by both founders underscores their commitment to maximizing the distinct opportunities that lie ahead for each company.

Mark Katakowski, who serves as the Chief Science Officer of Forever Labs, echoed these sentiments by highlighting that the separation allows each organization to actualize its unique vision without compromising the collaborative spirit they have nurtured since their inception.

As Kevin Virgil steps into his role, he brings with him a history of successfully founding and scaling businesses, including a data analytics company. He has long been acquainted with Forever Labs, being a client prior to his appointment. “I’ve been passionate about Forever Labs since I first became a client,” Virgil expressed. “Leading this remarkable team is both humbling and exhilarating. We are at the forefront of a revolution in longevity medicine and metabolic health, and I am dedicated to building on the exceptional foundation that Steven and Mark have laid.”

The leadership transition and spinout are effective immediately, with both Forever Labs and SuperShot maintaining their current operational locations. They will continue their existing research partnerships and customer commitments, ensuring that the shift will not disrupt service or innovation.

About Forever Labs

Forever Labs serves as a consumer healthcare company and operates the only ISO-certified adult stem cell processing laboratory in the United States. Their mission revolves around giving clients the ability to store their stem cells for prospective use in treating age-related conditions, injuries, and various chronic diseases.

About SuperShot Inc.

SuperShot Inc. is dedicated to the development of cutting-edge platelet-rich plasma (PRP) therapeutic interventions. The formation of SuperShot as a spinout from Forever Labs comes at a time of growing interest and potential in various healthcare applications, making it an exciting addition to the innovative landscape in medicine.

Both companies look toward a future filled with new possibilities and improved healthcare solutions that benefit patients and the broader community alike.